Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,581.3
-14.7 (-0.56%)

 

  • STI Straits Times Index
    2,581.3
    -14.7 (-0.56%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.6
    -11.8 (-0.75%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,183.0
    -47.7 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,360.1
    39.4 (1.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,289.4
    39.8 (0.17%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,247.7
    8.4 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,818.9M
  • Value: 1,195.1M
  • Rise: 145
  • Fall: 205
  • Unch: 458

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036-
Yinda Infocomm0.035-
Rex Intl0.168-0.013
ChinaKundaTech0.028+0.002
FJ Benjamin^0.020+0.002
Singapore-eDev0.062-0.012
Medtecs Intl1.610+0.050
ThaiBev0.605-
Kitchen Culture0.215-0.105
AnAn Intl0.037-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

FRONTAGE FRONTAGE
Quotes 15 Minutes Delayed. Updated at 14 Aug 2020 16:08
Last (HKD): 3.700 Change: -0.060 High: 3.840 Remarks: -
Change (%): -1.60 Low: 3.690
Open 3.760 Yesterday's Close 3.760
Buy Price 3.710 Sell Price 3.710
Buy Volume ('000) 22 Sell Volume ('000) 16
Cumulative Volume ('000) 4,766 Cumulative Value 17,931,920
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.07103 Trailing EPS (HKD) e 0.07103 NAV (HKD) b 1.0140
PE a 52.091 Trailing PE f 52.093 Price / NAV b 3.6489
Dividend (HKD) d - Cash In Hand (HKD) g 0.7979 Issued & Paid-up Shares c 2,033,280,000
Dividend Yield (%) d - Price / Cash In Hand g 4.637 Treasury Shares h -
Beta - 75 Daysi 0.991 R-Squared - 75 Days(%)i 15.72 Market Cap (M) 7,523.136
Beta - 500 Daysi 1.153 R-Squared - 500 Days (%)i 19.57 Enterprise Value (M) 6,069.038
Piotroski F Score 6 Exchange Code 1521 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 57.84 6-Month VWAP 4.208 Free Float (%) 36.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 23 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference FRONTAGE HKEx 7,523.136 52.091 52.093 3.6489 -
Industry Biotechnology HKEx 60,331.380 22.556 26.305 6.7063 2.221
Local Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Local Peer WUXI BIO HKEx 216,907.105 188.686 188.685 15.1677 -
Local Peer SINO BIOPHARM HKEx 172,873.016 56.324 56.839 4.9897 0.580
Local Peer BEIGENE HKEx 149,335.384 - - 7.5969 -
Local Peer GENSCRIPT BIO HKEx 29,593.630 - - 9.9215 -
Local Peer 3SBIO HKEx 23,883.934 21.632 21.632 2.2183 -
Local Peer VIVA BIOTECH HKEx 19,401.459 64.356 64.355 9.7584 0.161
Local Peer HAOHAI BIOTEC HKEx 18,160.099 43.194 43.194 3.0875 0.750
Local Peer ALPHAMAB-B HKEx 14,972.779 - - 5.5177 -
Local Peer ASCENTAGE-B HKEx 8,228.398 - - 8.2608 -
Local Peer KINTOR PHARMA-B HKEx 5,681.218 - - 15.3692 -
Local Peer SINOMAB BIO-B HKEx 3,431.278 - - 2.7100 -
Other Local Peers LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 140,396.709 17.903 19.235 13.1717 2.443
Global Peer CSL ASX 126,834.048 47.275 43.784 14.6656 0.950
Global Peer GILEAD SCIENCES INC NASDAQ 85,879.820 15.945 - 4.7640 3.715
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,620.224 59.160 33.459 9.2589 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,172.529 30.803 21.844 7.1955 -
Global Peer ILLUMINA INC NASDAQ 50,743.760 50.643 73.223 11.1207 -
Global Peer BIOGEN INC NASDAQ 45,823.698 7.782 7.732 4.0521 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,364.508 - - 15.0845 -
Global Peer MODERNA INC NASDAQ 27,285.691 - - 9.2591 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,568.244 9.387 26.673 2.1512 -
Other Global Peers BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ALKERMES PLC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VAXCYTE INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), VIELA BIO INC (NASDAQ), MESOBLAST LTD (ASX), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MYOVANT SCIENCES LTD (NYSE), ROCKET PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), COMPUGEN (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), POLYNOVO LIMITED (ASX), ITEOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VAXART INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RETROPHIN INC (NASDAQ), NKARTA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), PRECIGEN INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KADMON HLDGS INC (NYSE), AKOUOS INC (NASDAQ), AGENUS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ),